Standard BioTools Inc. Repayments of Long-Term Debt
Standard BioTools Inc. (LAB) reported Repayments of Long-Term Debt of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2023-03-14
- Standard BioTools Inc. repayments of long-term debt for the quarter ending 2022-12-31 was $0.00.
- Standard BioTools Inc. repayments of long-term debt for the quarter ending 2022-09-30 was $0.00.
- Standard BioTools Inc. repayments of long-term debt for the quarter ending 2022-06-30 was $0.00.
- Standard BioTools Inc. repayments of long-term debt for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- Standard BioTools Inc. repayments of long-term debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Standard BioTools Inc. repayments of long-term debt for fiscal 2021 was $501.00K.
- Standard BioTools Inc. repayments of long-term debt for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Standard BioTools Inc. repayments of long-term debt for fiscal 2019 was $51.83M.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $0.00 derived: sum of 2 quarters · filed 2023-03-14 | $0.00 derived: sum of 3 quarters · filed 2023-03-14 | $0.00 10-K · filed 2023-03-14 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 4 quarters · filed 2023-03-14 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $0.00 derived: sum of 3 quarters · filed 2023-03-14 | $0.00 derived: sum of 4 quarters · filed 2023-03-14 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-09 | $0.00 derived: sum of 2 quarters · filed 2023-03-14 | $0.00 derived: sum of 3 quarters · filed 2023-03-14 | $0.00 derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $0.00 derived: sum of 2 quarters · filed 2023-03-14 | $0.00 derived: sum of 3 quarters · filed 2023-03-14 | $501.00K 10-K · filed 2023-03-14 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $501.00K 10-Q · filed 2022-11-09 | $501.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $501.00K 10-Q · filed 2022-08-09 | $501.00K derived: sum of 3 quarters · filed 2022-08-09 | $501.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $501.00K 10-Q · filed 2022-05-09 | $501.00K derived: sum of 2 quarters · filed 2022-05-09 | $501.00K derived: sum of 3 quarters · filed 2022-05-09 | $501.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $0.00 derived: sum of 2 quarters · filed 2022-03-08 | $0.00 derived: sum of 3 quarters · filed 2022-03-08 | $0.00 10-K · filed 2022-03-08 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $0.00 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-07 | |||
| 2019-12-31 | $51.83M 10-K · filed 2022-03-08 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-25 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-27 | |||
| 2015-12-31 | $0.00 10-K · filed 2016-02-29 | |||
| 2014-12-31 | $0.00 10-K · filed 2016-02-29 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $0.00 derived: sum of 3 quarters · filed 2016-02-29 | $0.00 10-K · filed 2016-02-29 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $0.00 derived: sum of 2 quarters · filed 2013-11-07 | $0.00 10-Q · filed 2013-11-07 | $0.00 derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $0.00 10-Q · filed 2013-08-07 | $0.00 derived: sum of 3 quarters · filed 2015-02-26 | $2.84M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-09 | $0.00 derived: sum of 2 quarters · filed 2015-02-26 | $2.84M derived: sum of 3 quarters · filed 2015-02-26 | $6.37M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $2.84M derived: sum of 2 quarters · filed 2015-02-26 | $6.37M derived: sum of 3 quarters · filed 2015-02-26 | $10.19M 10-K · filed 2015-02-26 |
| 2012-09-30 | $2.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $6.37M derived: sum of 2 quarters · filed 2013-11-07 | $10.19M 10-Q · filed 2013-11-07 | $11.67M derived: sum of 4 quarters · filed 2014-03-12 |
| 2012-06-30 | $3.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $7.35M 10-Q · filed 2013-08-07 | $8.83M derived: sum of 3 quarters · filed 2014-03-12 | $10.26M derived: sum of 4 quarters · filed 2014-03-12 |
| 2012-03-31 | $3.82M 10-Q · filed 2013-05-09 | $5.29M derived: sum of 2 quarters · filed 2014-03-12 | $6.73M derived: sum of 3 quarters · filed 2014-03-12 | $8.11M derived: sum of 4 quarters · filed 2014-03-12 |
| 2011-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | $2.91M derived: sum of 2 quarters · filed 2014-03-12 | $4.29M derived: sum of 3 quarters · filed 2014-03-12 | $4.74M 10-K · filed 2014-03-12 |
| 2011-09-30 | $1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $2.82M derived: sum of 2 quarters · filed 2012-11-09 | $3.27M 10-Q · filed 2012-11-09 | $3.27M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $1.83M 10-Q · filed 2012-08-14 | $1.83M derived: sum of 3 quarters · filed 2013-03-12 | $1.83M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-03-31 | $447.00K 10-Q · filed 2012-05-15 | $447.00K derived: sum of 2 quarters · filed 2013-03-12 | $447.00K derived: sum of 3 quarters · filed 2013-03-12 | |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $0.00 derived: sum of 2 quarters · filed 2013-03-12 | $0.00 10-K · filed 2013-03-12 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-09 | |||
| 2009-12-31 | $1.03M 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |